ZAPPATERRA ARIANNA
Pubblicazioni
Civettini, I., Zappaterra, A., Corti, P., Messina, A., Aroldi, A., Biondi, A., et al. (2025). Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype. MED, 6(4) [10.1016/j.medj.2024.11.007]. Dettaglio
Deodato, M., Frustaci, A., Zappaterra, A., Rapella, A., Gambacorti-Passerini, C., Cairoli, R., et al. (2024). Advances in the understanding of molecular genetics and therapy ofRichter transformation in chronic lymphocytic leukemia. LEUKEMIA & LYMPHOMA, 65(14), 2096-2107 [10.1080/10428194.2024.2398660]. Dettaglio
Civettini, I., Zappaterra, A., Granelli, B., Rindone, G., Aroldi, A., Bonfanti, S., et al. (2024). Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making. BRITISH JOURNAL OF HAEMATOLOGY, 204(4 (April 2024)), 1523-1528 [10.1111/bjh.19200]. Dettaglio
Zappaterra, A., Civettini, I., Cafro, A., Pezzetti, L., Pierini, S., Anghilieri, M., et al. (2024). Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients. BLOOD TRANSFUSION, 22(4), 328-337 [10.2450/BloodTransfus.667]. Dettaglio
Carpenedo, M., Zappaterra, A., Del Castello, L., Ferrari, B., Cotilli, G., Bernasconi, D., et al. (2024). Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience. PLATELETS, 35(1) [10.1080/09537104.2024.2415483]. Dettaglio